Ubiquitin‐dependent regulation of MYC: a promising therapeutic target

Bryony G. Kennedy, Jonathan J. Morgan, Lisa J. Crawford*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

78 Downloads (Pure)

Abstract

Commentary on: Xiong Y, Wang L, Xu S, Fu B, Che Y, Zaky MY, Tian R, Yao R, Guo D, Sha Z, Lin F, Lin X, Wu H. Small molecule Z363 co-regulates TAF10 and MYC via the E3 ligase TRIP12 to suppress tumour growth. Clin Transl Med. 2023;13(1):e1153. doi: 10.1002/ctm2.1153

Original languageEnglish
Article numbere190
JournalClinical and Translational Discovery
Volume3
Issue number2
DOIs
Publication statusPublished - 01 Apr 2023

Keywords

  • COMMENTARY
  • E3 ligase
  • MYC
  • TRIP12
  • ubiqutin

Fingerprint

Dive into the research topics of 'Ubiquitin‐dependent regulation of MYC: a promising therapeutic target'. Together they form a unique fingerprint.

Cite this